SCHEMBL5167089

SCHEMBL5167089

CC(Cc1c[nH]c2ccccc12)N[C@H]1CC[C@](Cc2ccccc2)(N(C)C)CC1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
OPRL1 P41146 4/20 0.48
OPRM1 P35372 3/20 0.48
LMNA P02545 2/20 0.43
GAA P10253 1/20 0.43
HTR1D P28221 2/20 0.43
HTR1B P28222 2/20 0.43
ADRB1 P08588 1/20 0.43
HTR1A P08908 1/20 0.43
ADRA2A P08913 1/20 0.43
SLC6A2 P23975 1/20 0.43
HTR2A P28223 1/20 0.43
HTR2C P28335 1/20 0.43
HTR1E P28566 1/20 0.43
SLC6A4 P31645 1/20 0.43
HTR7 P34969 1/20 0.43
HTR2B P41595 1/20 0.43
HTR6 P50406 1/20 0.43
SLC6A3 Q01959 1/20 0.43
NR3C1 P04150 6/20 0.42
MAPT P10636 3/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5164225 1.00 OPRL1 (0.48) OPRL1OPRM1LMNAGAAHTR1D
SCHEMBL5164684 0.83 OPRL1 (0.70) OPRL1OPRM1HTR1DHTR1BADRB1
SCHEMBL12918432 0.83 OPRL1 (0.70) OPRL1OPRM1HTR1DHTR1BADRB1
SCHEMBL5164787 0.83 OPRL1 (0.69) OPRL1OPRM1LMNAGAAMAPT
Hydrochloric Acid SCHEMBL5164066 0.82 OPRL1 (0.69) OPRL1OPRM1HTR1DHTR1BADRB1
Hydrochloric Acid SCHEMBL5164262 0.82 OPRL1 (0.68) OPRL1OPRM1LMNAGAAMAPT
SCHEMBL5164138 0.78 OPRL1 (0.52) OPRL1OPRM1HTR1DHTR1BADRB1
Hydrochloric Acid SCHEMBL5164593 0.77 OPRL1 (0.51) OPRL1OPRM1HTR1DHTR1BADRB1
SCHEMBL30353988 0.77 HTR2A (0.51) LMNAHTR1DHTR1BADRB1HTR1A
SCHEMBL19412077 0.77 HTR2A (0.51) LMNAHTR1DHTR1BADRB1HTR1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7276518-B2 Substituted cyclohexane-1,4-diamine compounds GRUENENTHAL GMBH (DE) 2007-10-02 US disclosed
EP-1392641-B1 SUBSTITUTED CYCLOHEXANE-1,4-DIAMINE DERIVATIVES GRUENENTHAL GMBH (DE) 2007-04-11 EP disclosed
US-20040229872-A1 Substituted cyclohexane-1,4-diamine compounds with anti-diarrhea and peripheral analgesic activity GRUENENTHAL GMBH (DE) 2004-11-18 US disclosed
US-20040162287-A1 Substituted cyclohexane-1,4-diamine compounds GRUENENTHAL GMBH (DE) 2004-08-19 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040162287-A1 Substituted cyclohexane-1,4-diamine compounds DPYD, DDC, QDPR OPRL1 1102/4885OPRM1 459/4885LMNA 2350/4885
US-20040229872-A1 Substituted cyclohexane-1,4-diamine compounds with anti-diarrhea and peripheral analgesic activity ARG1, CD2, PDCD1 OPRL1 41/4885OPRM1 250/4885LMNA 4818/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.